Project Number 5R01AG031859-05 Agency/Funding Organization NIA Funding Year 2013 View Full Project Details for MECHANISMS OF PPAR-GAMMA ENHANCEMENT OF COGNITIVE FUNCTION IN ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 10. Metabolism and Bioenergetics b. Insulin Resistance and Type II Diabetes Researcher and Organization Principal Investigator KAYED, RAKEZ Principal Investigator First Name RAKEZ Principal Investigator Last Name KAYED Awardee Organization University of Texas Medical Branch Galveston Awardee State Texas Contact PI Country United States Project Detail Funding Opportunity Announcement PA-07-070: RESEARCH PROJECT GRANT (PARENT R01) FY Overall Cost $333,479 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA Related Resources Repository [AlzPED] Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status.